TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
Cell · 2023-08 · 186 (16) · 3427-3442.e22
DOI: 10.1016/j.cell.2023.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2023-08. Verfasst von Jim Baggen und 24 weiteren Autor:innen. Beteiligte Einrichtung: KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium. …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 155-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Cancer Research UK, Wellcome Trust.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium. Electronic address: jim.baggen@kuleuven.be.
- KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium.
- Chromatin Structure and Mobile DNA Laboratory, Francis Crick Institute, London NW1 1AT, UK.
- Structural Biology of Disease Processes Laboratory, Francis Crick Institute, London NW1 1AT, UK.
- Department of Chemistry, Britannia House, 7 Trinity Street, King's College London, London SE1 1DB, UK.
- Structural Biology Science Technology Platform, Francis Crick Institute, London NW1 1AT, UK.
Förderung
- Medical Research Council
- Cancer Research UK
- Wellcome Trust
- UK Research and Innovation
- FWO
- King's College London
- Francis Crick Institute
Zitieren
APA
Baggen, J., Jacquemyn, M., Persoons, L., Vanstreels, E., Pye, V. E., Wrobel, A. G., Calvaresi, V., Martin, S. R., Roustan, C., Cronin, N. B., Reading, E., Thibaut, H. J., Vercruysse, T., Maes, P., De Smet, F., Yee, A., Nivitchanyong, T., Roell, M., Franco-Hernandez, N., …, & Daelemans, D. (2023). TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell, 186(16), 3427-3442.e22. https://doi.org/10.1016/j.cell.2023.06.005
Vancouver
Baggen J, Jacquemyn M, Persoons L, Vanstreels E, Pye VE, Wrobel AG, et al. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell. 2023;186(16):3427-3442.e22. doi:10.1016/j.cell.2023.06.005
BibTeX
@article{Baggen2023,
author = {Baggen, Jim and Jacquemyn, Maarten and Persoons, Leentje and Vanstreels, Els and Pye, Valerie E and Wrobel, Antoni G and Calvaresi, Valeria and Martin, Stephen R and Roustan, Chloë and Cronin, Nora B and Reading, Eamonn and Thibaut, Hendrik Jan and Vercruysse, Thomas and Maes, Piet and De Smet, Frederik and Yee, Angie and Nivitchanyong, Toey and Roell, Marina and Franco-Hernandez, Natalia and Rhinn, Herve and Mamchak, Alusha Andre and Ah Young-Chapon, Maxime and Brown, Eric and Cherepanov, Peter and Daelemans, Dirk},
title = {TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry},
journal = {Cell},
year = {2023},
volume = {186},
number = {16},
pages = {3427--3442.e22},
doi = {10.1016/j.cell.2023.06.005}
}
EUVIMED